Home › Companies › PACIRA BIOSCIENCES INC. › 2023-2024
Compiled from SEC Form N-PX filings and PACIRA BIOSCIENCES INC.’s Form 8-K, filed 2024-06-13 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore PACIRA BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are PACIRA BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Laura Brege | 20,659,043 | -- | -- | 20,779,899 | 2,676,760 | Plurality election |
| Elect Director: Mark Froimson | 40,275,000 | -- | -- | 1,163,942 | 2,676,760 | Majority: yes |
| Elect Director: Mark Kronenfeld | 31,252,640 | -- | -- | 10,186,302 | 2,676,760 | Majority: yes |
| Elect Director: Michael Yang | 40,666,349 | -- | -- | 772,593 | 2,676,760 | Majority: yes |
| Proposal 2: Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. | 43,901,001 | 204,074 | 10,627 | -- | -- | Majority: yes |
| Proposal 3: Advisory vote to approve the compensation of the Company's named executive officers. | 37,228,983 | 4,087,635 | 122,324 | -- | 2,676,760 | Majority: yes |
Source: PACIRA BIOSCIENCES INC., Form 8-K, filed with the SEC on 2024-06-13 — read the filing on EDGAR.
Each item below shows how the 315 asset managers that disclosed a PACIRA BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PACIRA BIOSCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 10 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
PACIRA BIOSCIENCES INC.’s own tally for this item (“Proposal 3: Advisory vote to approve the compensation of the Company's named executive officers.”): 37,228,983 for, 4,087,635 against, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,517,410 outstanding shares: 80% for, 9% against (89% of the company cast a for/against vote).
The 312 asset managers below cast 93% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 7,105,031 | 416 | 0 | 0 | For |
| Vanguard | 5,963,782 | 0 | 0 | 0 | For |
| State Street | 2,594,295 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,620,024 | 0 | 0 | 0 | For |
| Dimensional | 1,585,534 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 1,418,391 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 1,296,449 | 0 | 0 | 0 | For |
| Clearbridge Investments, LLC | 1,171,977 | 0 | 0 | 0 | For |
| Stephens Investment Management Group LLC | 1,090,838 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,023,600 | 0 | 0 | 0 | For |
| Fidelity | 1,003,658 | 0 | 0 | 0 | For |
| Legg Mason | 997,440 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 976,276 | 0 | 0 | 0 | For |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 933,070 | 30,037 | 0 | 0 | For |
| Charles Schwab | 812,945 | 0 | 0 | 0 | For |
| Invesco | 743,018 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 14,415 | 724,563 | 0 | 0 | Against |
| Aberdeen | 0 | 715,734 | 0 | 0 | Against |
| Nuveen | 701,504 | 0 | 0 | 0 | For |
| Janus Henderson | 578,741 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD & CO LTD | 0 | 576,803 | 0 | 0 | Against |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0 | 576,121 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 556,879 | 0 | 0 | 0 | For |
| T. Rowe Price | 504,857 | 0 | 0 | 0 | For |
| Northern Trust | 474,335 | 30 | 0 | 0 | For |
Showing the 25 largest of 312 asset managers. See all 312 in the interactive database.
Combines 7 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
PACIRA BIOSCIENCES INC.’s own tally for this item (“Proposal 2: Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”): 43,901,001 for, 204,074 against, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,517,410 outstanding shares: 94% for, 0.5% against (95% of the company cast a for/against vote).
The 102 asset managers below cast 99.9% of the shares they voted on this item FOR (25,173,323 for, 652 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,834,940 | 0 | 0 | 0 | For |
| BlackRock | 5,376,254 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,620,024 | 0 | 0 | 0 | For |
| Dimensional | 1,405,769 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 1,296,449 | 0 | 0 | 0 | For |
| Fidelity | 997,869 | 0 | 0 | 0 | For |
| Legg Mason | 997,440 | 0 | 0 | 0 | For |
| State Street | 852,202 | 652 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 556,879 | 0 | 0 | 0 | For |
| TIAA | 406,000 | 0 | 0 | 0 | For |
| Charles Schwab | 396,013 | 0 | 0 | 0 | For |
| Invesco | 362,028 | 0 | 0 | 0 | For |
| DWS | 344,696 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 330,214 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 260,027 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 196,961 | 0 | 0 | 0 | For |
| T. Rowe Price | 194,586 | 0 | 0 | 0 | For |
| Aberdeen | 192,189 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 189,867 | 0 | 0 | 0 | For |
| Jackson National | 178,800 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 174,821 | 0 | 0 | 0 | For |
| Tributary Funds, Inc. | 163,535 | 0 | 0 | 0 | For |
| Empower | 154,091 | 0 | 0 | 0 | For |
| NICHOLAS Ltd EDITION, INC. | 152,350 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 135,720 | 0 | 0 | 0 | For |
Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.
Combines 4 wordings of this item as funds reported it.
49.9% Plurality election · of votes cast
PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Laura Brege”): 20,659,043 for, 20,779,899 withheld, per its Form 8-K filed 2024-06-13 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here. Of all 46,517,410 outstanding shares: 44% for, 45% withheld (89% of the company cast a for/withheld vote).
The 94 asset managers below cast 100% of the shares they voted on this item FOR (10,346,987 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 857,568 | 0 | 4,977,372 | 0 | Abstain |
| BlackRock | 0 | 0 | 5,376,254 | 0 | Abstain |
| Pacer Funds Trust | 1,620,024 | 0 | 0 | 0 | For |
| Dimensional | 1,405,769 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 1,296,449 | 0 | Abstain |
| Fidelity | 963,759 | 0 | 34,110 | 0 | For |
| Legg Mason | 997,440 | 0 | 0 | 0 | For |
| State Street | 14,208 | 0 | 838,646 | 0 | Abstain |
| JANUS INVESTMENT FUND | 556,879 | 0 | 0 | 0 | For |
| TIAA | 406,000 | 0 | 0 | 0 | For |
| Charles Schwab | 396,013 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 362,028 | 0 | Abstain |
| DWS | 0 | 0 | 344,696 | 0 | Abstain |
| GLENMEDE FUND INC | 330,214 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 260,027 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 196,961 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 194,586 | 0 | Abstain |
| Aberdeen | 192,189 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 181,338 | 0 | 8,529 | 0 | For |
| Jackson National | 178,800 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 174,821 | 0 | 0 | 0 | For |
| Empower | 35,057 | 0 | 119,034 | 0 | Abstain |
| NICHOLAS Ltd EDITION, INC. | 152,350 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 135,720 | 0 | 0 | 0 | For |
| Nuveen | 134,889 | 0 | 0 | 0 | For |
Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Mark Froimson”): 40,275,000 for, 1,163,942 withheld, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,517,410 outstanding shares: 87% for, 3% withheld (89% of the company cast a for/withheld vote).
The 94 asset managers below cast 100% of the shares they voted on this item FOR (24,511,662 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,834,940 | 0 | 0 | 0 | For |
| BlackRock | 5,376,254 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,620,024 | 0 | 0 | 0 | For |
| Dimensional | 1,405,769 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 1,296,449 | 0 | 0 | 0 | For |
| Fidelity | 997,869 | 0 | 0 | 0 | For |
| Legg Mason | 997,440 | 0 | 0 | 0 | For |
| State Street | 851,515 | 0 | 1,339 | 0 | For |
| JANUS INVESTMENT FUND | 556,879 | 0 | 0 | 0 | For |
| TIAA | 406,000 | 0 | 0 | 0 | For |
| Charles Schwab | 396,013 | 0 | 0 | 0 | For |
| Invesco | 362,028 | 0 | 0 | 0 | For |
| DWS | 344,696 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 330,214 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 260,027 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 196,961 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 194,586 | 0 | Abstain |
| Aberdeen | 192,189 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 189,867 | 0 | 0 | 0 | For |
| Jackson National | 178,800 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 174,821 | 0 | 0 | 0 | For |
| Empower | 154,091 | 0 | 0 | 0 | For |
| NICHOLAS Ltd EDITION, INC. | 152,350 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 135,720 | 0 | 0 | 0 | For |
| Nuveen | 134,889 | 0 | 0 | 0 | For |
Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.
Combines 5 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Mark Kronenfeld”): 31,252,640 for, 10,186,302 withheld, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,517,410 outstanding shares: 67% for, 22% withheld (89% of the company cast a for/withheld vote).
The 94 asset managers below cast 100% of the shares they voted on this item FOR (20,416,582 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,655,661 | 0 | 179,279 | 0 | For |
| BlackRock | 5,376,254 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,620,024 | 0 | 0 | 0 | For |
| Dimensional | 1,405,769 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 1,296,449 | 0 | Abstain |
| Fidelity | 997,869 | 0 | 0 | 0 | For |
| Legg Mason | 997,440 | 0 | 0 | 0 | For |
| State Street | 14,208 | 0 | 838,646 | 0 | Abstain |
| JANUS INVESTMENT FUND | 556,879 | 0 | 0 | 0 | For |
| TIAA | 406,000 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 396,013 | 0 | Abstain |
| Invesco | 0 | 0 | 362,028 | 0 | Abstain |
| DWS | 344,696 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 330,214 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 0 | 0 | 260,027 | 0 | Abstain |
| Columbia Threadneedle | 196,961 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 194,586 | 0 | Abstain |
| Aberdeen | 192,189 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 189,867 | 0 | 0 | 0 | For |
| Jackson National | 178,800 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 174,821 | 0 | 0 | 0 | For |
| Empower | 0 | 0 | 154,091 | 0 | Abstain |
| NICHOLAS Ltd EDITION, INC. | 152,350 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 135,720 | 0 | 0 | 0 | For |
| Nuveen | 134,889 | 0 | 0 | 0 | For |
Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Michael Yang”): 40,666,349 for, 772,593 withheld, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,517,410 outstanding shares: 87% for, 2% withheld (89% of the company cast a for/withheld vote).
The 94 asset managers below cast 100% of the shares they voted on this item FOR (24,820,067 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,834,940 | 0 | 0 | 0 | For |
| BlackRock | 5,376,254 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,620,024 | 0 | 0 | 0 | For |
| Dimensional | 1,405,769 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 1,296,449 | 0 | 0 | 0 | For |
| Fidelity | 997,869 | 0 | 0 | 0 | For |
| Legg Mason | 997,440 | 0 | 0 | 0 | For |
| State Street | 852,854 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 556,879 | 0 | 0 | 0 | For |
| TIAA | 406,000 | 0 | 0 | 0 | For |
| Charles Schwab | 396,013 | 0 | 0 | 0 | For |
| Invesco | 362,028 | 0 | 0 | 0 | For |
| DWS | 344,696 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 330,214 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 260,027 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 196,961 | 0 | 0 | 0 | For |
| T. Rowe Price | 194,586 | 0 | 0 | 0 | For |
| Aberdeen | 192,189 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 189,867 | 0 | 0 | 0 | For |
| Jackson National | 178,800 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 174,821 | 0 | 0 | 0 | For |
| Empower | 154,091 | 0 | 0 | 0 | For |
| NICHOLAS Ltd EDITION, INC. | 152,350 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 135,720 | 0 | 0 | 0 | For |
| Nuveen | 134,889 | 0 | 0 | 0 | For |
Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.
100% fund support · no official result
The 4 asset managers below cast 100% of the shares they voted on this item FOR (331,515 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| James Alpha Funds Trust | 166,760 | 0 | 0 | 0 | For |
| Tributary Funds, Inc. | 163,535 | 0 | 0 | 0 | For |
| SYNTAX ETF TRUST | 1,120 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 100 | 0 | 0 | 0 | For |
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Northern Lights Fund Trust IV | 12,131 | 0 | 0 | 0 | For |
| ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC | 655 | 0 | 0 | 0 | For |
Ranked by the number of PACIRA BIOSCIENCES INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 46,517,410 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 15.27% |
| 2 | Vanguard | 12.82% |
| 3 | State Street | 5.58% |
| 4 | Pacer Funds Trust | 3.48% |
| 5 | Dimensional | 3.41% |
| 6 | MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 3.05% |
| 7 | Delaware/Macquarie | 2.79% |
| 8 | Clearbridge Investments, LLC | 2.52% |
| 9 | Stephens Investment Management Group LLC | 2.35% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.20% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 15.77% | 13F |
| Vanguard Group | 11.17% | 13F |
| State Street | 4.09% | 13F |
| Renaissance Technologies | 4.05% | 13F |
| Dimensional Fund Advisors | 3.50% | 13F |
| Goldman Sachs | 2.82% | 13F |
| Morgan Stanley | 2.46% | 13F |
| Geode Capital | 2.23% | 13F |
| Nuveen | 1.22% | 13F |
| Invesco | 1.18% | 13F |
Percentages above are of 46,517,410 shares outstanding, as reported by PACIRA BIOSCIENCES INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PACIRA BIOSCIENCES INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At PACIRA BIOSCIENCES INC.'s shareholder meeting held 2024-06-11, in the 2023-2024 proxy season, 315 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,090 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of our named executive officers. — FOR was 90% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: PACIRA BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-13.
PACIRA BIOSCIENCES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.